Gray Hair Repigmentation in Androgenetic Alopecia Under Oral Minoxidil

A person in their early 30s has been using finasteride for about 10 years and recently started oral minoxidil, vitamin chewables, and dermarolling to address hair loss. They noticed pigmented vellus hairs and potential regrowth, questioning if oral minoxidil is more effective than topical due to enzyme differences.

Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.

A 35-year-old male used oral finasteride and topical minoxidil, later transitioning to oral minoxidil, to stop hair loss and improve hair density. He plans a future hair transplant and experienced temporary libido changes but no permanent side effects.

A 31-year-old male experienced significant hair regrowth on his crown after using oral minoxidil (initially 1.25 mg, increased to 2.5 mg, then reduced back to 1.25 mg) and finasteride (1 mg), without side effects except increased hair on arms, beard, and eyelashes. He also used anaphase conditioner and shampoo but no derma rolling or additional multivitamins.

The user experienced significant hair regrowth using topical Minoxidil and oral Finasteride over five months, with darker and thicker hair and new follicles appearing. They are considering waiting 1-2 years before deciding on a hair transplant, as further improvement is expected.

Oral minoxidil treatment increased hair density and shaft caliber in AGA patients. Side effects included hypertrichosis and lower extremity edema, with younger patients experiencing fewer side effects.